Next Article in Journal
Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
Previous Article in Journal
Identification of KIF11 As a Novel Target in Meningioma
Previous Article in Special Issue
Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer
Article Menu

Export Article

Open AccessArticle
Cancers 2019, 11(4), 546;

Frequent Occurrence of NRAS and BRAF Mutations in Human Acral Naevi

Department of Dermatology, Venerology and Allergology, University Hospital Essen, 45147 Essen, Germany
West German Cancer Center, University Hospital Essen, 45147 Essen, Germany
German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
Dermatological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Department of Dermatology, University of Cologne, 50937 Cologne, Germany
Department of Dermatology, University Hospital Heidelberg, 69120 Heidelberg, Germany
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany
Dermatopathologie bei Mainz, Bahnhofstraße 2 b, 55268 Nieder-Olm, Germany
Authors to whom correspondence should be addressed.
Received: 23 March 2019 / Revised: 9 April 2019 / Accepted: 10 April 2019 / Published: 16 April 2019
(This article belongs to the Special Issue Application of Next-Generation Sequencing in Cancers)
PDF [959 KB, uploaded 16 April 2019]
  |     |  


Acral naevi are benign melanocytic tumors occurring at acral sites. Occasionally they can progress to become malignant tumors (melanomas). The genetics of acral naevi have not been assessed in larger studies. In our study, a large cohort of 130 acral naevi was screened for gene mutations known to be important in other naevi and melanoma subtypes by targeted next-generation sequencing. Mutation status was correlated with clinicopathological parameters. Frequent mutations in genes activating the MAP kinase pathway were identified, including n = 87 (67%) BRAF, n = 24 (18%) NRAS, and one (1%) MAP2K1 mutations. BRAF mutations were almost exclusively V600E (n = 86, 99%) and primarily found in junctional and compound naevi. NRAS mutations were either Q61K or Q61R and frequently identified in dermal naevi. Recurrent non-V600E BRAF, KIT, NF1, and TERT promoter mutations, present in acral melanoma, were not identified. Our study identifies BRAF and NRAS mutations as the primary pathogenic event in acral naevi, however, distributed differently to those in non-acral naevi. The mutational profile of acral naevi is distinct from acral melanoma, which may be of diagnostic value in distinguishing these entities. View Full-Text
Keywords: acral; naevi; melanoma; genetics; dermatology acral; naevi; melanoma; genetics; dermatology

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Jansen, P.; Cosgarea, I.; Murali, R.; Möller, I.; Sucker, A.; Franklin, C.; Paschen, A.; Zaremba, A.; Brinker, T.J.; Stoffels, I.; Schadendorf, D.; Klode, J.; Hadaschik, E.; Griewank, K.G. Frequent Occurrence of NRAS and BRAF Mutations in Human Acral Naevi. Cancers 2019, 11, 546.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top